The Role of LAIs in Schizophrenia: Convenience, Adherence, and Access
Explore the benefits and challenges of long-acting injectables (LAIs) in managing schizophrenia for improved patient outcomes.
FluMist Home Delivery Expands Access to Seasonal Influenza Vaccination
FluMist Home, the first at-home nasal spray flu vaccine, is now available for direct delivery to patients in 34 US…
Therapeutic Response with Genialis – Life Sciences Today Podcast Episode 24
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest…
Iza-Bren Receives FDA Breakthrough Therapy Designation for EGFR-Mutated NSCLC
The action is supported by 3 ongoing clinical trials, which are evaluating izalontamab brengitecan (iza-bren) in non–small cell lung cancer…
Beyond the Buzz: Digital Health Needs a Reality Check—And That’s a Good Thing
The following is a guest article by Julien de Salaberry, CEO at Galen Growth For much of the past decade,…
Study: Apitegromab Meaningfully Improves Motor Function in Spinal Muscular Atrophy
Results from the phase 3 SAPPHIRE trial show significant improvements in motor function in children and adults with spinal muscular…
Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease
Ninth Acquisition in 18 Months Adds Brand, Creative, and Omnichannel Strength to Supreme Group’s Rapidly Growing Healthcare and Life Sciences…
Rising 340B Costs Drive Employer Spending and Spark Calls for Reform
Employers are facing higher costs and employees higher premiums as 340B’s growth drives lost rebates and rising drug prices.
Notebook shipment update, July 2025
Due to strong shipment momentum in the second quarter of 2025 and the off-season in the education market, the combined…
Nvidia to face trial in November over Valeo trade secret claims, US judge rules
A federal judge in California has ruled that Nvidia must stand trial in November over allegations it benefited from trade…